Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease
Open Access
- 1 November 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 70 (5) , 881-887
- https://doi.org/10.1093/ajcn/70.5.881
Abstract
Background: Elevated blood homocysteine is a risk factor for cardiovascular disease. A 5-μmol/L increase is associated with an ≈70% increase in relative risk of cardiovascular disease in adults. For patients with established risk factors, this risk is likely even greater. Objective: Effects of increased dietary folate and recommended intakes of vitamins B-12 and B-6 on serum total homocysteine (tHcy) were assessed in individuals at high risk of cardiovascular disease. Design: This trial was conducted at 10 medical research centers in the United States and Canada and included 491 adults with hypertension, dyslipidemia, type 2 diabetes, or a combination thereof. Participants were randomly assigned to follow a prepared meal plan (PMP; n = 244) or a self-selected diet (SSD; n = 247) for 10 wk, which were matched for macronutrient content. The PMP was fortified to provide ≥100% of the recommended dietary allowances for 23 micronutrients, including folate. Results: Mean folate intakes at 10 wk were 601 ± 143 μg/d with the PMP and 270 ± 107 μg/d with the SSD. With the PMP, serum tHcy concentrations fell from 10.8 ± 5.8 to 9.3 ± 4.9 μmol/L (P < 0.0001) between weeks 0 and 10 and the change was associated with increased intakes of folate, vitamin B-12, and vitamin B-6 and with increased serum and red blood cell folate and serum vitamin B-12 concentrations. tHcy concentrations did not change significantly with the SSD. Conclusions: The PMP resulted in increased intakes and serum concentrations of folate and vitamin B-12. These changes were associated with reduced serum tHcy concentrations in persons at high risk of cardiovascular disease.Keywords
This publication has 31 references indexed in Scilit:
- Prospective Studies of Homocysteine and Cardiovascular DiseaseNutrition Reviews, 2009
- Reduction of Plasma Homocyst(e)ine Levels by Breakfast Cereal Fortified with Folic Acid in Patients with Coronary Heart DiseaseNew England Journal of Medicine, 1998
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Serum Total Homocysteine and Coronary Heart DiseaseInternational Journal of Epidemiology, 1995
- Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folateThe American Journal of Cardiology, 1995
- Homocyst(e)ine and arterial occlusive diseasesJournal of Internal Medicine, 1994
- Treatment of mild hyperhomocysteinemia in vascular disease patients.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded DefinitionAnnual Review of Medicine, 1993
- Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular DiseaseAnnual Review of Nutrition, 1992
- Early signs of vascular disease in homocystinuria: A noninvasive study by ultrasound methods in eight families with cystathionine-β-synthase deficiencyMetabolism, 1990